Of 3 slblirgs one boy dled unexpectedly at 18 nlo, one girl 1s healthy and one girl was admitted at 3 yrs 9 mo wlLh heart fallure and signs of dllated cardlon~yopathy. Arialyses of blood collected for PKU-screen~ng showed low carnitlne conc in the patlent and her brother, but norn~al in her sister. Er~docardlal fibroelastosls and cardiomyopathy was found at autopsy of the dead boy, and similar changes in endon~yocard~al biopsies of the patient. Carnltine conc in her plasma was 1.2 pmol/l, lri skeletal muscle 0.01 pmol/g non-collagen protelr~ (NCP) and ir~ heart muscle 0.05 ,umol/g NCP: Skeletal muscle showed llpid accun~ulatlorr in type 1 fibres and marked atrophy of type 2 flbres.
Treatn~erit with oral L-carnitine resulted in rapid cllriical Improvnlerit, riormal~zatlon of echocardloqraphic variables and of the mvo- Oral tetrahydrobiopterin (THB) load has been recommended for the recognition of TlIB deficiency among hyperphenylalaninemic infants. In some patients with dihydropteridine reductnse (DlIPR) deficiency, the test has been reported to be ineffective. To explore such a resistance to THB, intestinalabsorp tion oC pteridines was investigated . In 10 control children the maximum biopterin (B) serum value was observed 4 hours after oral administration of 5 mgfkg THB. A wide range of B increase (14.6-190.5 nmolfl, mean : 73.2 nmolfl) was noted, suggesting a great variation in the intestinal absorption of THB. A constant rate intestinal perfusion study using a double lumen tube and polyethylene glycol 4000 as non absorbable marker was performed in 8 control infants and 1 adult.Pteridines were separated after acid and alcaline oxydation by ion-exchange HPLC chromatography. THB,B, and pterin mean absorption rates were as follows : THB = 14% (n=9), B=3% (n=3), pterin = 80 X (n=3). These results show a very low intestinal absorption of THB and B in man, and suggest the limiting role of the lateral chain 6-dihydroxypropyl, present in THB and B, and absent in pterin. They could explain the resistance to TllB during the oral loading test in DllPR deficient patients. Two daughters of related Turkish parents were investigated at the ages of 11 8/12 and 16 8/12 years for severe neurologic disease. This was characterised by pronounced psychomotor retardation, ataxia, dysmetria, dystonia and choreiform movements. Both girls were moderately obese and showed macrocephaly without dysmorphy. Laboratory investigation revealed increased protidorhachia (120 and 47 mg/dl), and increased cerebrospinal fluid lysine (80 and 50 pM; nl 10-25) and urinary 2-hydroxyglutaric acid (400-500 pM/g creatinine; nl < 1). Plasma and urinary lysine as well as cerebrospinal fluid 2-hydroxyglutaric acid were normal except for a slightly increased plasma lysine in one patieqt (270 rU; nl 60-230). Electromyography and nerve conduction velocity were normal. Computerised tomography of the brain was suggestive of leukodystrophy. Conclusion: this seems to be a previously unreported hereditary metabolic disorder. Its basic defect remains to be determined. This study was undertaken to investigate the molecular basis of the two different clinical phenotypes (acute and chronic forms) of type 1 tyrosinemia (fumarylacetoacetase deficiency). Fumarylacetoacetase (FAA) was isolated from beef liver and antibodies raised in rabbits. Analysis of fibroblasts extracts by immunoblotting showed the absence of cross-reacting material in cells from acute patients and reduced amounts in cells from chronic patients. Fibroblasts from controls nd from both acute and chronic patients were pulselabeled with 3'S-methionine followed by a chase of 1-4 days.
PROTEINASE INHIBITOR COZ-PHE

DIFFERENT TYPES OF MU'PATIObIS IN CIIYONIC AND ACUTE FORMS
Radioactively labeled FAA was immunoprecipitated with proteinAcoupled antibody, dissociated and subjected to SDS-PAGE followed by fluorography. In control fibroblasts after pulse-labeling two bands could be visualized, the upper band having a molecular size of 41.200 daltons, the lower band 0.5-1.0 kilodaltons s!naller.These bands disappeared after 4 days. In fibroblasts frbm acute patients the M=41.200 band after synthesis disappeared within 1 day while in cells from chronic patients the rate of disappearance was in between . These results indicate that the acute and chronic forms of type ltyrosinemia are caused by different types of mutations. In the chronic form of tyrosinemia renal tubular dysfunction with secondary hypphosphatemic rickets usually is a major finding. Three patients, two brothers and one girl, had at the age of 5.12 and 15 years no generalized hyperaminoaciduria, nor clinical signs of rickets. Untreated the elder brother had only slightly elevated serum tyrosine, 1 4 1~1 (noml(80), and low excre lon of p0H-phenyllactate. He had pronounced trcmbxytopenia
6'
(8x10 /1). The brother presented 21 m n t h s old with l a r g~ liver. S e m tyrosine was 318pl/l, the trcmbxyte count 48x10 /1. Succinylacetone was elevated in urine in both. The third patient was investigated for hepatmgaly in infancy, k t developed n o m lly without treatment until she contracted hepatoma at the age of 15 years. Her plasm tyrosine level was 600 -7 0 0 p l / l , she excreted large amunts of poll-phenyllactate and succinylacetone in urine was low but elevated, 8 mol creatinine. The fumarylacetoacetase activity in fibroblasts from both brothers and in l w ocytes from the girl was less than 5 % of normal level. Lack of renal tubular dysfunction in patients with the chronic form of tyrosinemia, is unusual. However; absence of this finding should not preclude the search for this diagnosis in patients otherwise suspected for hereditary tyrosinemia.
